Forge Investment Outlook Q2 2024Road to Recovery: Private Market Accelerates in Q1
Forge Investment Outlook Q2 2024
Trading
Data
Solutions
Insights
About
EndoGastric Solutions is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
EndoGastric Solutions is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own EndoGastric Solutions pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
EndoGastric Solutions is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 11/25/2020 | Series J | $27MM raised | $XXX.XX | $XXX.XX |
| 5/28/2019 | Series I | $45MM raised | $XXX.XX | $XXX.XX |
| 7/10/2018 | Series H | $15.2MM raised | $XXX.XX | $XXX.XX |
| 5/6/2014 | Series G and G-1 | $29.88MM raised | $XXX.XX | $XXX.XX |
| 6/21/2012 | Series F | $37.17MM raised | $XXX.XX | $XXX.XX |
| 11/25/2009 | Series E | $15.26MM raised | $XXX.XX | $XXX.XX |
| 8/31/2007 | Series D | $8.54MM raised | $XXX.XX | $XXX.XX |
| 2/23/2006 | Series C | $8.89MM raised | $XXX.XX | $XXX.XX |
| 9/11/2004 | Series B | $1.31MM raised | $XXX.XX | $XXX.XX |
| 4/8/2003 | Series A | $737.3K raised | $XXX.XX | $XXX.XX |
